Cargando…
Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients
BACKGROUND: CCNY, a novel cyclin family member, plays an increasingly important role in the progression of tumor invasion and metastasis, including lung cancer. However, the clinical significance of CCNY in non-small-cell lung cancer (NSCLC) patients is unknown. PATIENTS AND METHODS: We prepared CCN...
Autores principales: | Ma, Li, Gu, Meng, Teng, Yu, Li, Weiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357874/ https://www.ncbi.nlm.nih.gov/pubmed/30774378 http://dx.doi.org/10.2147/OTT.S180507 |
Ejemplares similares
-
Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
por: Ma, Li, et al.
Publicado: (2013) -
CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse
por: Zi, Zhenzhen, et al.
Publicado: (2015) -
CCNI2 plays a promoting role in the progression of colorectal cancer
por: Lai, Dong‐Ming, et al.
Publicado: (2021) -
The Candidate IBD Risk Gene CCNY Is Dispensable for Intestinal Epithelial Homeostasis
por: Molinas, Andrea, et al.
Publicado: (2021) -
CCNI2 promotes the progression of human gastric cancer through HDGF
por: Chen, Wenchao, et al.
Publicado: (2021)